Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
CPSC Warns E-Scooter, E-Bike Manufacturers to Adhere to Safety Standards Amid Battery Fire, Accident Reports This year alone, the CPSC has received more than 200 battery fire or overheating reports linked to E-Scooter, E-bike and other micromobility device manufacturers. December 29, 2022 Russell Maas Add Your Comments Federal regulators are warning manufacturers and distributors of e-scooter and other micromobility devices to make sure the batteries in their products comply with federal safety standards, following a number of reports involving lithium ion battery fires. The U.S. Consumer Product Safety Commission (CPSC) issued a letter on December 20, instructing more than 2,000 manufacturers and importers of e-scooters, self-balancing scooters, e-bicycles and e-unicycles to take immediate action to ensure the devices comply with Underwriter Laboratories (UL) safety standards. E-scooter and other micromobility devices containing poorly designed or manufactured lithium ion batteries have been an ongoing concern for years, with the CPSC having announced numerous recalls due to the devices being prone to overheating, smoldering catching on fire and even exploding. While the CPSC has worked with UL to develop a series of safety standards for electrical systems used in these devices, the agency is finding many e-scooter, e-bike and hoverboard manufacturers are failing to adhere to the applicable safety standards, putting consumers at an unnecessary and unreasonable risk of serious injury. The CPSC announced in the latest warning that from January 1, 2021, through November 28, 2022, the agency has received at least 208 micromobility fire or overheating incident reports across 38 states. Of these incidents, 19 have resulted in fatal injuries, with 5 deaths associated with e-scooters, 11 with hoverboards, and 3 with e-bikes. The agency has also become aware of at least 22 injuries that resulted in emergency department visits, with 12 of the injuries involving e-scooters and 10 of them involving e-bikes. New Micromobility Device Certification Standards As a result of the growing number of micromobility device fires and the substantial hazards they pose to consumers, the CPSC says it will now require more than 2,000 manufacturers, distributors, importers and retailers to demonstrate their products are in compliance with the standards through certification from an accredited testing laboratory. The agency stated companies that fail to provide such certification will be subject to enforcement action, and even penalties. Furthermore, the agency stated under Section 15(b) of the CPSA, 15 U.S.C. § 2064(b), every manufacturer, importer, distributor, and retailer of consumer products is required to notify the agency when information becomes available that a product introduced into commerce contains a defect that could lead to hazards. The letter indicated failure to abide by the statute and communicate with the CPSC on hazardous product findings could lead to both civil and criminal penalties. Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION E-Scooter, E-Bike and Hoverboard Hospitalizations Leading up to the recent warning letter sent to thousands of manufacturers and distributors, the CPSC released a report in October, titled “Micromobility Products-Related Deaths, Injuries, and Hazard Patterns”, which warned there has been a 127% increase in hospitalizations caused by e-bikes, hoverboards and e-scooters crashes between 2017 and 2021. In the report, officials gathered the latest available statistics on injury estimates, fatalities, and hazard patterns associated with e-scooters, hoverboards, and e-bikes. For all of the micromobility devices, the agency estimated a total of 267,700 emergency department visits occurred in 2021, representing a sharp increase from prior years. Of all of the emergency department visits recorded, 117,600 were caused by personally owned or rented e-scooter crashes. CPSC researchers also found the rate of emergency department visits from e-scooters drastically increased, rising from 7,700 in 2017 to 42,200 in 2021. E-scooters were the most common cause of micromobility-related ER visits. Officials found hoverboards were the second most common cause of micromobility related emergency department visits, with 121,300 reports. However, the report noted a 15% reduction in treatments between 2020 and 2021. E-bikes accounted for 11 percent of the overall micromobility injury estimates. Tags: Battery, Burns, E-Bike, E-scooter, Explosion, Fire, Hoverboard, Lithium Ion Batteries, Micromobility More Lawsuit Stories Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker March 12, 2025 MDL Judge Dismisses Gardasil Lawsuits, Finding Failure To Warn Claims Preempted by Federal Laws March 12, 2025 Early Fluoride Exposure Could Affect Children’s Cognitive Abilities: Study March 12, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: today) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025) Suboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (Posted: yesterday) Suboxone lawyers will meet today with a federal judge, to discuss the status of thousands of tooth decay lawsuits brought over the opioid treatment film strips. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITMedical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)Another Influx of Suboxone Tooth Decay Lawsuits Expected in Coming Months (01/20/2025) 75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (Posted: 2 days ago) The MDL Judge will hear presentations from Depo-Provera lawyers seeking leadership positions during a two day hearing on March 13th and 14th, as a growing number of women continue to file brain tumor lawsuits against the makers of the popular birth control shot. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025)Judge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)
MDL Judge Dismisses Gardasil Lawsuits, Finding Failure To Warn Claims Preempted by Federal Laws March 12, 2025
Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: today) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)
Suboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (Posted: yesterday) Suboxone lawyers will meet today with a federal judge, to discuss the status of thousands of tooth decay lawsuits brought over the opioid treatment film strips. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITMedical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)Another Influx of Suboxone Tooth Decay Lawsuits Expected in Coming Months (01/20/2025)
75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (Posted: 2 days ago) The MDL Judge will hear presentations from Depo-Provera lawyers seeking leadership positions during a two day hearing on March 13th and 14th, as a growing number of women continue to file brain tumor lawsuits against the makers of the popular birth control shot. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025)Judge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)